npr.org
This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
This is what I was afraid of. As more evidence mounts that the obesity epidemic is caused by something environmental (either a change in dietary composition or a toxin of some sort), a "cure" has arrived just before the root cause has been proven. Instead of targeting the root cause and removing whatever is causing obesity from the environment, slimness will now be sold to those who can afford it. I think even if researchers identified the cause of obesity, there would be a lot of incentive to keep the obesity train rolling, to everyone's detriment.
And obesity is just the most visible symptom of metabolic disease. Could we still be at increased risk of cancer, heart disease, etc even with these miracle drugs?
I'm not suggesting any explicit conspiracy here, but I can't help notice a terrifying convergence of incentives. One corporation makes money by selling us cheap, addictive, poisoned food. Another corporation makes money by selling us a partial cure for the poison in our food. The incentives align to never, ever find a better solution to this problem, and to suppress it if it is discovered.
More options
Context Copy link
More options
Context Copy link